Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes-Reference-Cited by-同舟云学术

Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes

Published:2016-11-21 Issue:2 Volume:19 Page:290-293
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Wu Tongzhi¹²,Xie Cong¹²³,Wu Hang¹²³,Jones Karen L.¹²,Horowitz Michael¹²,Rayner Christopher K.¹²

Affiliation:

1. Discipline of Medicine; University of Adelaide; Adelaide South Australia Australia

2. Centre of Research Excellence in Translating Nutritional Science to Good Health; University of Adelaide; Adelaide South Australia Australia

3. Medical School; Southeast University; Nanjing China

Funder

Royal Adelaide Hospital Research Committee Early Career Fellowship

National Health and Medical Research Council

Merck Sharp and Dohme

Eli Lilly and Company

Boehringer Ingelheim

Sanofi

Novartis

Novo Nordisk

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12812/fullpdf

Reference15 articles.

1. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies;Buse;Diabetes Care,2016

2. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin;Bahne;Diabetes Obes Metab,2016

3. Incretins;Wu;Handb Exp Pharmacol,2016

4. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell;Mulherin;Endocrinology,2011

5. Cholecystokinin-induced gallbladder emptying and metformin elicit additive glucagon-like peptide-1 responses;Rohde;J Clin Endocrinol Metab,2016

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study;Frontiers in Endocrinology;2024-02-02

2. Proposed treatment strategy for reactive hypoglycaemia;Frontiers in Endocrinology;2024-02-02

3. Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review;Frontiers in Molecular Biosciences;2023-10-10

4. Ameliorative effects of Orlistat and metformin either alone or in combination on liver functions, structure, immunoreactivity and antioxidant enzymes in experimentally induced obesity in male rats;Heliyon;2023-08

5. A randomized clinical trial comparing low-fat with precision nutrition–based diets for weight loss: impact on glycemic variability and HbA1c;The American Journal of Clinical Nutrition;2023-08